Abstract

Zinc–copper (ZnCu) alloys recently showed great potential as biodegradable materials for bone implants thanks to their excellent mechanical strength, biosafety, and promising bioactivities. However, bare ZnCu alloys exhibited poor cytocompatibility and osteointegration. Moreover, the biological functions of ZnCu remain to be corroborated. Herein, the teriparatide (PTH)-mediated strontium–zinc phosphate (SrZnP) organic–inorganic hybrid coating was fabricated on the surface of ZnCu substrate via a chemical conversion method to contain the release of Zn ions and improve biofunctionality in osteogenesis. The characteristics of the hybrid coating were optimised by adjusting the amount of PTH molecules added. A dense and homogenous coating with micellar crystal micro-/nano-structure was obtained. The coated samples showed a significantly decreased corrosion rate and a more uniform corrosion mode, effectively suppressing the release of Zn2+. Additionally, the coated ZnCu enhanced the proliferation of bone marrow mesenchymal stem cells (BMSCs), promoted the expression of alkaline phosphatase and the formation of calcium nodules, and upregulated the levels of osteogenic-related genes. More important, the hybrid coating activated the classic osteogenic signalling pathway of BMP-2/Smad1/Runx2 and Sirt1/Runx2 to induce the osteogenic differentiation of BMSCs. These appealing features can be mainly attributed to the constituents of released Zn2+, Sr2+, and PTH molecules in the control, as well as the unique topographical characteristics of the coatings. Taken together, the PTH&SrZnP hybrid coating could be a promising option for surface modification of biodegradable metallic Zn for orthopaedic applications.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call